|
|
Article: DermTech's EGIR Designed To Identify Diseases Through Skin.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
What started out as a clinical research organization in 1996 evolved last year into an early stage biotechnology company called DermTech International.
As a new player in the field of theranostics, DermTech focuses on its Epidermal Genetic Information Retrieval (EGIR) technology, which could be used in drug discovery, managed care and point-of-care testing. Theranostics is the parallel development of a diagnostic kit that can help select patients who will be most responsive to a therapy.
"This is a new, very important field. The FDA is very supportive of it," said Gail Naughton, chairwoman of DermTech and the dean of business at ...